 Morgan Stanley lessened its stake in Cue Biopharma Inc NASDAQ:CUE by 48.4 in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 39,202 shares of the companys stock after selling 36,826 shares during the quarter. Morgan Stanleys holdings in Cue Biopharma were worth 556,000 ... 